You searched for Liveyon

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities

October 8, 2024 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Back in late August, Liveyon leader John Kosolcharoen pleaded to federal charges on stem cells. What was Liveyon? Liveyon was a splashy umbilical cord stem cell supplier company. I don’t know if the company is still active now. One of its core products ended up sending dozens of people to the hospital due to contamination […]

Liveyon made $21.6 million says DOJ; leader gets 3 years prison for stem cell activities Read More »

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells

August 27, 2024 / Professor Paul Knoepfler, Ph.D. / 2 Comments

The stem cell clinic arena is a Wild West but perhaps few have been wilder than the perinatal stem cell clinic firm Liveyon run by John Kosolcharoen. Now John Kosolcharoen has pleaded guilty to felony charges related to Liveyon’s activities including distribution of an unapproved cell therapy drug. He will be sentenced next month. This

Liveyon leader John Kosolcharoen pleads to federal felony charges on stem cells Read More »

Feds want $3M, prison for Liveyon founder in old fraud case

March 2, 2022 / Professor Paul Knoepfler, Ph.D. / Leave a Comment

Before starting the umbilical cord cell supplier and marketing firm Liveyon, John Kosolcharoen was involved in some alleged health care fraud. The feds brought a case against him related to prescription drugs. Older case coming to a head As Liveyon was having its misadventures in the stem cell clinic sphere, the status of that past

Feds want $3M, prison for Liveyon founder in old fraud case Read More »

Liveyon product hurt many more patients says new CDC study

October 26, 2021 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Liveyon is a cord blood product marketer that distributed a batch of cells a couple of years back that led to many patients being hospitalized with infections. Some had sepsis and ended up in the ICU. It was thought at the time that about a dozen patients who had been injected with the Liveyon product

Liveyon product hurt many more patients says new CDC study Read More »

Liveyon is back (again) with unproven exosome product

March 12, 2020 / Professor Paul Knoepfler, Ph.D. / 11 Comments

Remember our old friends Liveyon? Their leader John Kosolcharoen? Liveyon’s continuing metamorphosis This biologics supply firm has gone through several stages of corporate metamorphosis as a supplier of biologics including at first a purported living umbilical cord stem cell product. That stem cell thrust ultimately landed a dozen or more people in the hospital as

Liveyon is back (again) with unproven exosome product Read More »

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon?

January 15, 2020 / Professor Paul Knoepfler, Ph.D. / 8 Comments

What’s Liveyon up to these days? A new, somewhat mysterious short film that serves as an advertisement for unproven exosomes has some of us scratching our heads. It seems to point to Liveyon. Can you guys as readers of The Niche help solve the puzzle of who’s behind this wild “cinematic commercial” and what the

Mystery of wild sci-fi film ad for unproven exosomes: Liveyon? Read More »

Why did clinic supplier Liveyon halt sales but others kept going despite FDA?

December 16, 2019 / Professor Paul Knoepfler, Ph.D. / 1 Comment

Umbilical “stem cell” supplier Liveyon has suspended sales of its products according to the WaPo after a harsh FDA warning letter. While not fully shutting off the tap to the perinatal stem cell clinic universe, as other suppliers including in Utah seem to be continuing, this Liveyon voluntary hold will equal a major reduction in

Why did clinic supplier Liveyon halt sales but others kept going despite FDA? Read More »

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms

December 9, 2019 / Professor Paul Knoepfler, Ph.D. / 13 Comments

Friday and Saturday showed a burst in FDA activity related to unproven stem cells and regenerative products including a warning letter to the unproven perinatal “stem cell” provider Liveyon. This was an unusual 48-hour period and a very good one for those who believe in science-based regenerative medicine but in my view a bad day

FDA spike: clinic supplier Liveyon warning letter & 483s; notice on exosome harms Read More »

Dissecting Liveyon FDA inspection report & troubled perinatal stem cell industry

May 29, 2019 / Professor Paul Knoepfler, Ph.D. / 1 Comment

The perinatal stem cell clinic supplier Liveyon has had many issues recently including an FDA inspection that in my view didn’t go well and which I’ll return to in a minute. First, some background on the company and this troubled industry. E. coli and other pathogens ended up in some of the Liveyon product somehow

Dissecting Liveyon FDA inspection report & troubled perinatal stem cell industry Read More »

Search Results for: Liveyon